Micrographia Bio is an applied AI-first life sciences company pioneering a new era of drug discovery through spatial proteomics. We dive deep into visualising individual proteins and their interactions in their native spatial context, and have developed an end-to-end platform for the quantification of changes in protein behaviour and mechanism of action at scale. By revealing where and how proteins interact, we unlock unprecedented insights into complex biology to increase the probability of success at the earliest stages of discovery. We are advancing internal pipeline therapeutic candidates focused on fundamental cellular pathways, and partner with drug discovery programmes to characterise mechanism of action with precision. Learn more at www.Micrographiabio.com, or connect on LinkedIn.
| Website | http://www.micrographiabio.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology, Drug Discovery |
| Keywords | Drug Discovery, Drug Development, Proteomics, Protein Analysis, Spatial Biology, New Drug Development, Biotechnology, Omics, Pharmaceutical, Biomarkers, Therapeutics, Clinical Development, Precision Medicine, Therapeutic Antibodies, Research Tools, Biopharma, Molecular Diagnostics, Life Sciences |
| Competitors | Thermo Fisher Scientific, BD, Agilent Technologies, Illumina, ZEISS Group, PerkinElmer, Inc., Bio-Rad Laboratories, Leica Biosystems, Molecular Devices, Evosys - your digital real estate partner +32 more (view full list) |
Looking for a particular Micrographia Bio employee's phone or email?
Christopher Thompson is the Co-founder and CTO of Micrographia Bio.
10 people are employed at Micrographia Bio.
Micrographia Bio is based in London, England.